Loading…

Increased T‐cell turnover is associated with spondyloarthritis in virally suppressed patients with HIV‐1 infection

Objectives Spondyloarthritis (SpA) is one of the most frequently observed inflammatory joint diseases in HIV‐1‐seropositive patients. T‐cells were described frequently as one of the major driving forces in SpA, therefore we tried to look for T‐cell aberrancies in our HIV‐positive patients with SpA....

Full description

Saved in:
Bibliographic Details
Published in:HIV medicine 2015-04, Vol.16 (4), p.255-260
Main Authors: Lu, I‐N, Meyer‐Olson, D, Stoll, M, Witte, T, Schmidt, RE, Baerlecken, NT
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3939-3c2123a23e09257f73e3be8b441f52b0e52b6987ae2e5607c7c76a4fd5bcca443
cites cdi_FETCH-LOGICAL-c3939-3c2123a23e09257f73e3be8b441f52b0e52b6987ae2e5607c7c76a4fd5bcca443
container_end_page 260
container_issue 4
container_start_page 255
container_title HIV medicine
container_volume 16
creator Lu, I‐N
Meyer‐Olson, D
Stoll, M
Witte, T
Schmidt, RE
Baerlecken, NT
description Objectives Spondyloarthritis (SpA) is one of the most frequently observed inflammatory joint diseases in HIV‐1‐seropositive patients. T‐cells were described frequently as one of the major driving forces in SpA, therefore we tried to look for T‐cell aberrancies in our HIV‐positive patients with SpA. Methods A total of 1098 files for HIV‐positive patients who attended the HIV out‐patient clinic of the Department of Clinical Immunology and Rheumatology at the Medical University Hanover for at least one visit between January 2004 and December 2010 were screened for the presence of a diagnosis of SpA. A cross‐sectional study was conducted to investigate aberrancies in T‐cell homeostasis induced by HIV‐1 in these subjects. Results The prevalence of SpA in the HIV‐positive patients was 1.6% (18 of 1098). Interestingly, the percentage of patients with SpA who were human leucocyte antigen (HLA)‐B27 negative in our HIV‐positive cohort was 80%. Despite combination antiretroviral therapy (cART) and viral suppression, an incomplete immune recovery of T‐cell naïve/memory distribution and turnover, as identified by intracellular Ki‐67 expression, was observed in HIV‐positive patients with SpA. Conclusions Independent of HLA‐B27 status and despite cART, HIV‐positive patients can develop SpA and exhibit an increased T‐cell turnover rate.
doi_str_mv 10.1111/hiv.12199
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1668255736</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1668255736</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3939-3c2123a23e09257f73e3be8b441f52b0e52b6987ae2e5607c7c76a4fd5bcca443</originalsourceid><addsrcrecordid>eNqNkd9KwzAUh4Mobk4vfAHppV50y7-m7aUMdYOBN9PbkmanLNK1NUk3eucj-Iw-idk6vRPMgSSQLx-c80PomuAx8Wuy1tsxoSRNT9CQcJGEhKbs9HDnIRWCDtCFtW8Yk5il-BwNaOQL42SItvNKGZAWVsHy6-NTQVkGrjVVvQUTaBtIa2ulpfPvO-3WgW3qatWVtTRubbTzhK6CrTayLLvAtk1jwO5ljXQaKmf7X7P5q5cTzxagnK6rS3RWyNLC1fEcoZfHh-V0Fi6en-bT-0WoWMrSkClKKJOUAU5pFBcxA5ZDknNOiojmGPwm0iSWQCESOFa-hOTFKsqVkpyzEbrtvY2p31uwLttou29SVlC3NiNCJDSKYib-g3KKeURjj971qDK1tQaKrDF6I02XEZztE8l8ItkhEc_eHLVtvoHVL_kTgQcmPbDTJXR_mzI_xF75DWmWmJk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1664204527</pqid></control><display><type>article</type><title>Increased T‐cell turnover is associated with spondyloarthritis in virally suppressed patients with HIV‐1 infection</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Lu, I‐N ; Meyer‐Olson, D ; Stoll, M ; Witte, T ; Schmidt, RE ; Baerlecken, NT</creator><creatorcontrib>Lu, I‐N ; Meyer‐Olson, D ; Stoll, M ; Witte, T ; Schmidt, RE ; Baerlecken, NT</creatorcontrib><description>Objectives Spondyloarthritis (SpA) is one of the most frequently observed inflammatory joint diseases in HIV‐1‐seropositive patients. T‐cells were described frequently as one of the major driving forces in SpA, therefore we tried to look for T‐cell aberrancies in our HIV‐positive patients with SpA. Methods A total of 1098 files for HIV‐positive patients who attended the HIV out‐patient clinic of the Department of Clinical Immunology and Rheumatology at the Medical University Hanover for at least one visit between January 2004 and December 2010 were screened for the presence of a diagnosis of SpA. A cross‐sectional study was conducted to investigate aberrancies in T‐cell homeostasis induced by HIV‐1 in these subjects. Results The prevalence of SpA in the HIV‐positive patients was 1.6% (18 of 1098). Interestingly, the percentage of patients with SpA who were human leucocyte antigen (HLA)‐B27 negative in our HIV‐positive cohort was 80%. Despite combination antiretroviral therapy (cART) and viral suppression, an incomplete immune recovery of T‐cell naïve/memory distribution and turnover, as identified by intracellular Ki‐67 expression, was observed in HIV‐positive patients with SpA. Conclusions Independent of HLA‐B27 status and despite cART, HIV‐positive patients can develop SpA and exhibit an increased T‐cell turnover rate.</description><identifier>ISSN: 1464-2662</identifier><identifier>EISSN: 1468-1293</identifier><identifier>DOI: 10.1111/hiv.12199</identifier><identifier>PMID: 25252008</identifier><language>eng</language><publisher>England</publisher><subject>Adult ; antiretroviral ; Cross-Sectional Studies ; Female ; HIV ; HIV Infections - complications ; HIV Infections - epidemiology ; HIV Infections - immunology ; HLA-B27 Antigen - metabolism ; Human immunodeficiency virus ; Human immunodeficiency virus 1 ; Humans ; Lymphocyte Activation ; Male ; Middle Aged ; osteoarthritis ; Prevalence ; Spondylarthritis - epidemiology ; Spondylarthritis - immunology ; Spondylarthritis - metabolism ; spondyloarthritis ; T-Lymphocytes - immunology ; T‐cell turnover ; Viral Load</subject><ispartof>HIV medicine, 2015-04, Vol.16 (4), p.255-260</ispartof><rights>2014 British HIV Association</rights><rights>2014 British HIV Association.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3939-3c2123a23e09257f73e3be8b441f52b0e52b6987ae2e5607c7c76a4fd5bcca443</citedby><cites>FETCH-LOGICAL-c3939-3c2123a23e09257f73e3be8b441f52b0e52b6987ae2e5607c7c76a4fd5bcca443</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25252008$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lu, I‐N</creatorcontrib><creatorcontrib>Meyer‐Olson, D</creatorcontrib><creatorcontrib>Stoll, M</creatorcontrib><creatorcontrib>Witte, T</creatorcontrib><creatorcontrib>Schmidt, RE</creatorcontrib><creatorcontrib>Baerlecken, NT</creatorcontrib><title>Increased T‐cell turnover is associated with spondyloarthritis in virally suppressed patients with HIV‐1 infection</title><title>HIV medicine</title><addtitle>HIV Med</addtitle><description>Objectives Spondyloarthritis (SpA) is one of the most frequently observed inflammatory joint diseases in HIV‐1‐seropositive patients. T‐cells were described frequently as one of the major driving forces in SpA, therefore we tried to look for T‐cell aberrancies in our HIV‐positive patients with SpA. Methods A total of 1098 files for HIV‐positive patients who attended the HIV out‐patient clinic of the Department of Clinical Immunology and Rheumatology at the Medical University Hanover for at least one visit between January 2004 and December 2010 were screened for the presence of a diagnosis of SpA. A cross‐sectional study was conducted to investigate aberrancies in T‐cell homeostasis induced by HIV‐1 in these subjects. Results The prevalence of SpA in the HIV‐positive patients was 1.6% (18 of 1098). Interestingly, the percentage of patients with SpA who were human leucocyte antigen (HLA)‐B27 negative in our HIV‐positive cohort was 80%. Despite combination antiretroviral therapy (cART) and viral suppression, an incomplete immune recovery of T‐cell naïve/memory distribution and turnover, as identified by intracellular Ki‐67 expression, was observed in HIV‐positive patients with SpA. Conclusions Independent of HLA‐B27 status and despite cART, HIV‐positive patients can develop SpA and exhibit an increased T‐cell turnover rate.</description><subject>Adult</subject><subject>antiretroviral</subject><subject>Cross-Sectional Studies</subject><subject>Female</subject><subject>HIV</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - epidemiology</subject><subject>HIV Infections - immunology</subject><subject>HLA-B27 Antigen - metabolism</subject><subject>Human immunodeficiency virus</subject><subject>Human immunodeficiency virus 1</subject><subject>Humans</subject><subject>Lymphocyte Activation</subject><subject>Male</subject><subject>Middle Aged</subject><subject>osteoarthritis</subject><subject>Prevalence</subject><subject>Spondylarthritis - epidemiology</subject><subject>Spondylarthritis - immunology</subject><subject>Spondylarthritis - metabolism</subject><subject>spondyloarthritis</subject><subject>T-Lymphocytes - immunology</subject><subject>T‐cell turnover</subject><subject>Viral Load</subject><issn>1464-2662</issn><issn>1468-1293</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqNkd9KwzAUh4Mobk4vfAHppV50y7-m7aUMdYOBN9PbkmanLNK1NUk3eucj-Iw-idk6vRPMgSSQLx-c80PomuAx8Wuy1tsxoSRNT9CQcJGEhKbs9HDnIRWCDtCFtW8Yk5il-BwNaOQL42SItvNKGZAWVsHy6-NTQVkGrjVVvQUTaBtIa2ulpfPvO-3WgW3qatWVtTRubbTzhK6CrTayLLvAtk1jwO5ljXQaKmf7X7P5q5cTzxagnK6rS3RWyNLC1fEcoZfHh-V0Fi6en-bT-0WoWMrSkClKKJOUAU5pFBcxA5ZDknNOiojmGPwm0iSWQCESOFa-hOTFKsqVkpyzEbrtvY2p31uwLttou29SVlC3NiNCJDSKYib-g3KKeURjj971qDK1tQaKrDF6I02XEZztE8l8ItkhEc_eHLVtvoHVL_kTgQcmPbDTJXR_mzI_xF75DWmWmJk</recordid><startdate>201504</startdate><enddate>201504</enddate><creator>Lu, I‐N</creator><creator>Meyer‐Olson, D</creator><creator>Stoll, M</creator><creator>Witte, T</creator><creator>Schmidt, RE</creator><creator>Baerlecken, NT</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>201504</creationdate><title>Increased T‐cell turnover is associated with spondyloarthritis in virally suppressed patients with HIV‐1 infection</title><author>Lu, I‐N ; Meyer‐Olson, D ; Stoll, M ; Witte, T ; Schmidt, RE ; Baerlecken, NT</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3939-3c2123a23e09257f73e3be8b441f52b0e52b6987ae2e5607c7c76a4fd5bcca443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>antiretroviral</topic><topic>Cross-Sectional Studies</topic><topic>Female</topic><topic>HIV</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - epidemiology</topic><topic>HIV Infections - immunology</topic><topic>HLA-B27 Antigen - metabolism</topic><topic>Human immunodeficiency virus</topic><topic>Human immunodeficiency virus 1</topic><topic>Humans</topic><topic>Lymphocyte Activation</topic><topic>Male</topic><topic>Middle Aged</topic><topic>osteoarthritis</topic><topic>Prevalence</topic><topic>Spondylarthritis - epidemiology</topic><topic>Spondylarthritis - immunology</topic><topic>Spondylarthritis - metabolism</topic><topic>spondyloarthritis</topic><topic>T-Lymphocytes - immunology</topic><topic>T‐cell turnover</topic><topic>Viral Load</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lu, I‐N</creatorcontrib><creatorcontrib>Meyer‐Olson, D</creatorcontrib><creatorcontrib>Stoll, M</creatorcontrib><creatorcontrib>Witte, T</creatorcontrib><creatorcontrib>Schmidt, RE</creatorcontrib><creatorcontrib>Baerlecken, NT</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>HIV medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lu, I‐N</au><au>Meyer‐Olson, D</au><au>Stoll, M</au><au>Witte, T</au><au>Schmidt, RE</au><au>Baerlecken, NT</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased T‐cell turnover is associated with spondyloarthritis in virally suppressed patients with HIV‐1 infection</atitle><jtitle>HIV medicine</jtitle><addtitle>HIV Med</addtitle><date>2015-04</date><risdate>2015</risdate><volume>16</volume><issue>4</issue><spage>255</spage><epage>260</epage><pages>255-260</pages><issn>1464-2662</issn><eissn>1468-1293</eissn><abstract>Objectives Spondyloarthritis (SpA) is one of the most frequently observed inflammatory joint diseases in HIV‐1‐seropositive patients. T‐cells were described frequently as one of the major driving forces in SpA, therefore we tried to look for T‐cell aberrancies in our HIV‐positive patients with SpA. Methods A total of 1098 files for HIV‐positive patients who attended the HIV out‐patient clinic of the Department of Clinical Immunology and Rheumatology at the Medical University Hanover for at least one visit between January 2004 and December 2010 were screened for the presence of a diagnosis of SpA. A cross‐sectional study was conducted to investigate aberrancies in T‐cell homeostasis induced by HIV‐1 in these subjects. Results The prevalence of SpA in the HIV‐positive patients was 1.6% (18 of 1098). Interestingly, the percentage of patients with SpA who were human leucocyte antigen (HLA)‐B27 negative in our HIV‐positive cohort was 80%. Despite combination antiretroviral therapy (cART) and viral suppression, an incomplete immune recovery of T‐cell naïve/memory distribution and turnover, as identified by intracellular Ki‐67 expression, was observed in HIV‐positive patients with SpA. Conclusions Independent of HLA‐B27 status and despite cART, HIV‐positive patients can develop SpA and exhibit an increased T‐cell turnover rate.</abstract><cop>England</cop><pmid>25252008</pmid><doi>10.1111/hiv.12199</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1464-2662
ispartof HIV medicine, 2015-04, Vol.16 (4), p.255-260
issn 1464-2662
1468-1293
language eng
recordid cdi_proquest_miscellaneous_1668255736
source Wiley-Blackwell Read & Publish Collection
subjects Adult
antiretroviral
Cross-Sectional Studies
Female
HIV
HIV Infections - complications
HIV Infections - epidemiology
HIV Infections - immunology
HLA-B27 Antigen - metabolism
Human immunodeficiency virus
Human immunodeficiency virus 1
Humans
Lymphocyte Activation
Male
Middle Aged
osteoarthritis
Prevalence
Spondylarthritis - epidemiology
Spondylarthritis - immunology
Spondylarthritis - metabolism
spondyloarthritis
T-Lymphocytes - immunology
T‐cell turnover
Viral Load
title Increased T‐cell turnover is associated with spondyloarthritis in virally suppressed patients with HIV‐1 infection
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T21%3A21%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20T%E2%80%90cell%20turnover%20is%20associated%20with%20spondyloarthritis%20in%20virally%20suppressed%20patients%20with%20HIV%E2%80%901%20infection&rft.jtitle=HIV%20medicine&rft.au=Lu,%20I%E2%80%90N&rft.date=2015-04&rft.volume=16&rft.issue=4&rft.spage=255&rft.epage=260&rft.pages=255-260&rft.issn=1464-2662&rft.eissn=1468-1293&rft_id=info:doi/10.1111/hiv.12199&rft_dat=%3Cproquest_cross%3E1668255736%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3939-3c2123a23e09257f73e3be8b441f52b0e52b6987ae2e5607c7c76a4fd5bcca443%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1664204527&rft_id=info:pmid/25252008&rfr_iscdi=true